SUMMARY-Subclinical glomerular immune complex disease was found in 9 of 94 kidneys obtained post mortem from patients with lymphoma and leukemia. The incidence was highest in patients with acute myelocytic leukemia (16%) and lowest in patients with solid Iymphoreticular malignancies (3%). Evidence was obtained that an antigen related to the interspecies (gs-3) antigen of mammalian oncornaviruses was present in the kidneys of 2 patients with acute myelocytic leukemia. The high incidence of immune complex disease in kidneys from patients with acute leukemia, as well as the presence of the gs-3 antigen in 2 of these patients, parallels experience demonstrating the presence of this disease in AKR mice and suggests homology in the etiology of human and murine leukemia.-J Natl Cancer Inst 50: 633-644,1973.
SEVERAL chronic viral infections in man and animals are now known to be associated with an immune complex nephritis. In diseases such as lymphocytic choriomeningitis in mice (1), Aleutian disease of mink (2), and Australia antigen-associated human hepatitis (3), host antibody, viral antigen, and complement are deposited in a granular pattern along glomerular capillary walls and in the mesangia. Whether this occurs in all viral infections is not known. Studies of serum sickness glomerulonephritis suggest that the viral infections causing these deposits are characterized by chronicity of infection and minimal host immune response, thus enabling the formation of soluble antigenantibody complexes which are in antigen excess (4).
Therefo're we postulated that immunofluorescent examination of kidneys for 'Y-and ,BiC-globulins might be the first step in detection of a minimal host response to viral or other antigens in patients with lymphoma-leukemia. These 2 globulins in the same glomerular loci are evidence of immunologic injury [secondary to an antibody response to basement membrane, to planted antigen, or deposition of circulating immune complexes (5)]. Primary distribution of these globulins in a segmental or irregular pattern suggests injury secondary to the deposition of circulating immune complexes (6). Antigens localized in such complexes can be identified by kidney sections stained with specific viral antisera and by analysis of whole kidney fractions through immunoprecipitation in double gel diffusion or complement fixation.
The validity of this approach has been strengthened by Old stone et al. (7) and Markham et al. (8) , who found immune complex deposition in the glomeruli of AKR mice with spontaneous leukemia. Mouse 'Y-and ,B1O-globulins were demonstrated in the glomeruli of these mice by immunofluorescent staining. Further staining with antisera to the G (Gross) antigen (7) and the group-specific antigens of the internal nucleoid (8) of murine leukemia virus identified the antigens in these complexes.
We now have evidence that immune complex disease can be found in at least 10% of kidneys at autopsy of lymphoma-leukemia patients with no clinical or histologic evidence of glomerulonephritis. Three of these patients were discussed in (9). The incidence of immune complex disease (as determined at autopsy) in patients without lymphoma or leukemia and without clinical or histologic evidence of glomerulonephritis was 3%.
MATERIALS AND METHODS
Clinical material.-The distribution of patients according to diagnoses is given in table 1. At autopsy, blocks of cortical tissue were snap-frozen in an acetone-dry ice slurry and stored, along with whole kidney tissue, at -70° C.
Fluorescent antibody studies.-Cryostat-cut sections of renal cortex containing glomeruli were fixed in absolute acetone for 10 minutes, washed for 3 minutes and 10 minutes in phosphate-buffered saline (PBS) at pH 7.2, and stained directly with fluorescein-labeled antisera for 45 minutes at room temperature. When indirect staining was used, the tissue was incubated with unlabeled antibody for 45 minutes at room temperature, washed twice with PBS, and restained with fluoresceinated al: tisera. In tests for viral antigen, kidney sections were incubated at 37° C in 0.12M glycine buffer (pH 3.2) for I hour, washed twice in PBS, fixed in acetone, and stained either directly or indirectly. An exception was the use of both acid-eluted and uneluted sections with murine and feline leukemia viral antisera.
The following fluorescein-conjugated antisera from varied sources were used: poly-specific goat anti-human gamma globulin (lgG, IgA, and IgM) (Certified Blood Donor Service, Inc., Woodbury, N.Y.; Melpar Biological Products, Springfield, Va.; Hyland Laboratories, Costa Mesa, Calif.), rabbit anti-human Betarc globulin (Certified Blood Donor Service, Inc.), rabbit anti-human fibrinogen (Certified Blood Donor Service, Inc.), rabbit anti-human albumin (Certified Blood Donor Service, Inc.), goat anti-rabbit gamma globulin (lgG) (Hyland Laboratories; Cappell Laboratories, Downingtown, Pa.), goat anti-mouse gamma globulin (lgG) (Hyland Laboratories), rabbit anti-guinea pig gamma globulin (lgG) (Microbiological Associates, Inc., Bethesda, Md.), and rabbit anti-rat gamma globulin (lgG) (Microbiological Associates, Inc.) . These antisera were initially tested by immuno-electrophoresis for strength and specificity before use.
Eleven viral and viral-related antisera were used in staining kidneys and in double diffusion analysis. Viralinfected cell monolayered coverslips (prepared by Dr. Roger Wilsnack, Huntingdon Research Center, Baltimore, Md.) served as positive controls for the strength and specificity of these antisera as well as for the quality of our staining procedures. These antisera and their positive controls are given in table 2.
Three rabbit antisera to feline leukemia virus (FeLV) were donated by Dr. Hardy. One was directed to ethertreated FeLV of cat tumor source (FeLVAbI); the others to ether-treated FeLV of tissue culture source (FeLVAb2 and FeLVAb3). Method of preparation and evidence of antivirion activity were detailed in (11). We found that all 3 sera stained cat fibroblasts infected with FeLV ( methenamine silver, and by the Jones allochrome and periodic acid-Schiff methods.
Separation if antigen-antibody complexes in whole kidney
homogenates.-Renal cortex was separated from medulla, homogenized, and washed several times in PBS. The homogenate was suspended in 0.02M glycine buffer (pH 3.2) at a ratio of 20 ml bufferJI g homogenate (16). This mixture was incubated at 37° C for 60 minutes and then centrifugedat 1700Xgfor 15 minutes.
resuspending it in PBS, and disrupting it by sonic vibration at 20,000 cycles per second for 3 minutes with a model WHO sonifier cell disruptor (Heat Systems-Ultrasonics, Inc., Plainview, N.Y.). Fraction A was then centrifuged at 1700Xg for 15 minutes and separated into sediment (fraction C) and supernatant (fraction D). Fraction D was then concentrated by vacuum dialysis.
The sediment (fraction A) and supernatant (fraction B) were separated. Fraction B was adjusted to 0.15M by the addition of 1M NaCI and to pH 7 by the addition ofK 2 HP0 4 • It was dialyzed extensively against PBS and concentrated by vacuum dialysis. We tried to make possible antigen in fraction A soluble by washing the fraction once with PBS, VOL. 50, NO.3, MARCH 1973 Double diffusion ana!J>sis.-Double diffusion analysis was performed in 0.5% agarose containing barbital buffer, pH 8.6, ionic strength 0.045, on standard microscope slides in a hexagon pattern of 6 wells around a central well (well size, 3 mm diameter; center to center from each well, 6 mm) at 4° C. Patterns of precipitation were photographed on high contrast film (Polaroid 51) in a darkfield light source.
RESULTS

ImmunoFluorescent Staining For Immune Complexes
,),-Globulin with !11O-globulin was found in the kidneys of 9 patients (an incidence of 10%-9/94) and ,),-globulin alone was found in the kidneys of another 3 (table 1). Of 144 kidneys from patients without lymphoma or leukemia, 4 had ')'-and !11O-globulin (an incidence of 3%-4/144), and another 8 had ,),-globulin alone. The highest occurrence of both ')'-and !1lC-globulins in the lymphomaleukemia group was in patients with acute myelocytic leukemia (16%-6/37); the lowest was in patients with solid lymphoreticular malignancies (3%-1/32). Representative positivities for both ')'-and !11O-globulins are shown in figures 1-8. Positivity was predominantly distributed in the capillaries (figs. 1-4, 7, 8), though positive staining within mesangial areas was occasionally present (figs. 5, 6). Positive staining for the human fibrinogen-fibrin system was found in 11 kidneys. No fluorescence was seen in glomeruli stained with fluoresceinated antihuman albumin.
Kidneys posltlve for ,),-globulin with or without !11O-globulin were stained with the battery of viral and viral-related antisera. Table  3 shows the results up to now. There were positive findings in 3 kidneys, 2 (#1 and 11, table 3) with antisera to FeLV and 1 (#3, table 3) with antiserum to M. pneumoniae (to be reported later).
The 2 patients positive for FeLV antigen were a 25-year-old white man and a 65-year-old white woman (#1, 11, table 3, respectively), both with acute myelocytic leukemia. ,),-Globulin in a glomerulus of the first patient is shown in figure  9 . The distribution is primarily in the capillaries, as is the distribution of !11O-globulin ( fig. 10 ). When acid-eluted sections of this kidney were stained by the indirect method with rabbit antiserum against ether-treated FeLV of cat tumor source (FeLVAbl), an extensive fluorescence involved both capillary loops and mesangia ( fig. 11) . A similar fluorescence was noted when we used in vitro-absorbed rabbit antiserum against ethertreated FeLV of tissue culture source (FeLVAb2). In contrast to this marked positivity, control kidneys (8) were consistently completely negative when stained with FeLVAb2. We could not test the specificity of staining with these antisera by The distribution of '}'-globulin in a glomerulus from the second pa tien t (# 11) is shown in figure 12 . The distribution is primarily in the capillaries and is similar to that of i3IC-globulin ( fig. 13) .
When sections of this kidney (#11) were stained with FeL V Ab3 (in vivo-and in vitro-absorbed FeLV antiserum) there was positive fluorescence, primarily in a capillary pattern ( fig. 14) . This fluorescence could be completely inhibited by absorption of this antiserum with ether-treated FeL V of tissue culture source and by absorption with ether-treated MuLV. Sections of this kidney could not be stained with only the fluoresceinated antirabbit '}'-globulin. Eight normal kidneys (donated by the Medical Examiner of Baltimore City) from accident and homicide victims could not be stained with Fe LV Ab3.
Light Microscope Findings
Most kidneys examined by light microscopy appeared normal. Rarely, a thickened capillary loop could be identified by careful examination.
Analyses of Fractions of Whole Kidney Homogenates
Four kidneys from patients with acute myelocytic leukemia (#1, 3, 4, 11, table 3) were homogenized and separated into fractions B (acid eluate) and D (disrupted precipitate), as described in "Materials and Methods." Two of these kidneys (#1, 11) stained with FeLV antiserum, another (#3) stained with antiserum to M. pneumoniae, and the other (#4) was negative when stained with the entire battery of viral and viral-related antisera. The final protein concentrations of fractions Band D from these kidneys are given in table 4.
Fractions B of all 4 kidneys were tested against ether-treated FeL V for immunoprecipitation in double gel diffusion, and no precipitin lines were observed. When fractions D of kidneys 3, 4, and 11 were similarly tested against rabbit anti-FeL V of cat tumor source, no precipitin lines were seen. When fraction D of kidney #1 was tested against this antiserum, however, a single line of precipitation was seen ( fig. 15 ). Because of the possibility of incomplete separation of antigen-antibody complexes by acid elution, fractions Band D were each tested for complementfixing activity against both oncornaviral antigen and antibody. They were further tested for the presence of oncornaviral antibody by complement fixation inhibition (19). The tests were performed without knowledge of the results of the antiviral immunoftourescent stains of these kidneys. The results of these tests are given in table 4. Only kidneys #1 and 11, which stained with antisera to FeL V, gave positive findings. Fraction B of kidney #1 had a complement fixation inhibition titer of I :8, whereas fractions D of kidneys # 1 and 11 both showed complement-fixing titers for oncornaviral antigen of I :8. These titers are moderately strong when the source of the materials tested and their protein concentrations are considered (20).
DISCUSSION
Immune complex disease can be found in the kidneys of lymphoma-leukemia patients examined at autopsy. The presence of 'Y-and ,sIC-globulins in the same loci and their distribution in a segmental or irregular pattern in 9/94 kidneys are strong evidence of immunologic injury (5) secondary to the deposition of circulating complexes (6). Our initial hypothesis-that the kidneys might be the place to look for host response to an unknown antigen, whether viral or otherwise-is supported by these findings.
The specificity of the stains of kidneys #1 and II (table 3) with antisera to an oncornaviral antigen is supported by I) the gel diffusion studies ( fig. 16) Our studies indicate that 1) the interspecies (gs-3) antigen of the mammalian oncornaviruses is present in the immune complexes in the glomeruli of kidneys #1 and II (table 3) , and 2) the species antigen (gs-I) of FeLV is not present in kidney #11. The first conclusion is based on the demonstrated specificity for gs-3 activity (see above) of the reference system used in the complement fixation tests for antigens, positive for both kidneys, and on the complement fixation inhibition test for antibody, positive for kidney #1. In kidney #11, ether-treated MuLV, which shares only the interspecies (gs-3) antigen with the internal nucleoid of FeLV (14, 15) , can completely inhibit staining by Fe LV antiserum; thus it also supports this conclusion. The second conclusion is based on the demonstrated activity (see "Materials and Methods") of the F eL V antiserum (FeL V Ab3) for both the gs-I and gs-3 antigens. The blocking activity of ether-treated MuLV not only confirms the presence of gs-3 but also excludes the presence of gs-l.
The presence of both gs-l and gs-3 implies that this patient (#11, table 3) might have been infected with FeLV. Patient #1 had no known association with cats. We do not know if the second patient (#11) was associated with cats. The presence of only the interspecies antigen would suggest the possibility of another mammalian leukemia virus, possibly a human leukemia virus. We think this is the most likely explanation.
The high incidence of immune complex nephritis in patients with acute myelocytic leukemia is similar to that found in kidneys of AKR mice with spontaneous leukemia (7, 8) and suggests homology in the etiology of human and murine leukemia. Studies of the kidneys of cats with spontaneous leukemia are still in progress. Anderson and Jarrett, however, noted membranous glomerulonephritis in 3 of 21 cats with spontaneous leukemia (21). Preliminary work done jointly in our laboratory and in that of Dr. Hardy shows that an immune complex nephritis does exist in cats with spontaneous leukemia.
Our studies do not reveal the identities of the antigens in 6 other kidneys with immune complexes and possibly 3 with /,-globulin alone (table O. Besides viral antigens not included in our battery, there> is the possibility that tumor-specific antigens cause immune complex disease, as Lewis et al. (22) described in a 57-year-old man who presented with the nephrotic syndrome and bronchial carcinoma.
Continued screening of kidneys from patients with lymphoma and leukemia as described should give more information about the connection between chronic viral infections and lymphomaleukemia.
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( 1) FIGURE l.-,),-Globulin in glomerulus from a 60-year-old white man with acute myelocytic leukemia (#4, table 3). Positive fluorescence, primarily in a capillary pattern. X 300 FIGURE 2.-i31C-Globulin in glomerulus from same kidney as in figure 1 . Pattern of positivity similar to that of ,),-globulin. X 300 FIGURE 3.-,),-Globulin in glomerulus from a 35-year-old white man with acute lymphocytic leukemia (#5, table 3). Distribution of positivity is primarily capillary. X 300 FIGURE 4.-i31C-Globulin in a glomerulus from same kidney as in figure 3 . Pattern of positivity similar to that of ,),-globulin. X 300
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SUTHERLAND AND MARDINEY FIGURE 5.--y-Globulin in glomerulus from a 17-year-old white man with acute lymphocytic leukemia (#6, table 3). Distribu_ tion of positivity is a mixture of capillary and mesangial. X 300 FIGURE 6.-I'lIC-Globulin in glomerulus from same kidney as in figure 5 . Distribution, like that of -y-globulin, is both capillary and mesangial. X 300 FIGURE 7.--y-Globulin in glomerulus of a 29-year-old white woman with acute myelocytic leukemia (#12, table 3). Distribution of positivity is primarily capillary. X 300 FIGURE 8.-I'lIC-Globulin in glomerulus from same kidney as in figure 7 . Distribution is primarily capillary. Note staining of hilar vessel. X 300 SUTHERLAND AND MARDINEY
